Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Barata, F
Camacho, E
Sousa, A
Costa, MS
Resende, R
Meleiro, A
Nogueira, F
Pereira, A
Canário, D
机构：
[1] Ctr Hosp Coimbra, Coimbra, Portugal
[2] Hosp Nossa Senhora Rosario, Barreiro, Portugal
[3] Hosp Univ Coimbra, Coimbra, Portugal
[4] Hosp Distrital Santarem, Santarem, Portugal
[5] Hosp Amato Lusitano, Castelo Branco, Portugal
[6] Hosp S Bernardo, Setubal, Portugal
[7] Hosp Egas Moniz, Lisbon, Portugal
[8] Hosp Distrital Fig Foz, Figueira Foz, Portugal
[9] Hosp Garcis Orta, Almada, Portugal
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [21] Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer
    Nagel, Sylke
    Califano, Raffaele
    Thatcher, Nicholas
    Blackhall, Fiona
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (18) : 3265 - 3275
  • [22] Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
    Martinez, Pablo
    Peters, Solange
    Stammers, Timothy
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2019, 25 (09) : 2691 - 2698
  • [23] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [24] A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
    Rodrigues-Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae Ho
    Wang, Jie
    Ganju, Vinod
    Martinez-Barrera, Luis
    Barraclough, Helen
    van Kooten, Maximiliano
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1907 - 1914
  • [25] A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    Kasahara, Kazuo
    Kimura, Hideharu
    Shibata, Kazuhiko
    Araya, Tomoyuki
    Sone, Takashi
    Oribe, Yoshitaka
    Furusho, Shiho
    Kita, Toshiyuki
    Shirasaki, Hiroki
    Oribe, Yoshitaka
    Yoshimi, Yuzo
    Ueda, Akihito
    Tachibana, Hideki
    Shintani, Hiromoto
    Mizuguchi, Masayuki
    Nishi, Kohichi
    Fujimura, Masaki
    Nakao, Shinji
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3723 - 3728
  • [26] Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
    Ozguroglu, Mustafa
    Evrensel, Turkkan
    Er, Ozlem
    Turna, Hande
    Yanmaz, Teoman
    Yildiz, Ozcan
    Mandel, Nil
    Serdengecti, Suheyla
    ANNALS OF ONCOLOGY, 2006, 17 : 225 - 225
  • [27] Efficacy and safety of docetaxel plus oxaliplatin as a first-line chemotherapy in patients with advanced or metastatic non-small cell lung cancer
    Ban, Heejung
    Kim, Kyu-Sik
    Oh, In-Jae
    Yoon, Seong-Hoon
    Lee, Boram
    Yu, Jinyeong
    Kim, Sunmin
    Lee, Ho-Sung
    Shin, Hong-Joon
    Park, Cheol-Kyu
    Kwon, Yong-Soo
    Kim, Yu-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    THORACIC CANCER, 2014, 5 (06) : 525 - 529
  • [28] Nedaplatin or Oxaliplatin Combined with Paclitaxel and Docetaxel as First-Line Treatment for Patients with Advanced Non-Small Cell Lung Cancer
    Zhang, Keqian
    Qin, Hong
    Pan, Feng
    Liu, Enqiang
    Liang, Houjie
    Ruan, Zhihua
    MEDICAL SCIENCE MONITOR, 2014, 20 : 2830 - 2836
  • [29] Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer
    Montalar, J
    Morales, S
    Maestu, I
    Camps, C
    Vadell, C
    García, R
    Yuste, AL
    Torregrosa, D
    Segura, A
    LUNG CANCER, 2001, 34 (02) : 305 - 311
  • [30] Randomized multicenter phase II study with docetaxel in combination with either cisplatin or oxaliplatin as first-line treatment in patients with advanced or metastatic non-small cell lung cancer
    Atmaca, A.
    Al-Batran, S.
    Guener, T.
    Pauligk, C.
    Koepke, A.
    Bernhard, H.
    Wenzel, T.
    Banat, A. G.
    Brueck, P.
    Caca, K.
    Prasnikar, N.
    Kullmann, F.
    Jaeger, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345